MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The average price target is $20.00 with a high forecast of $20.00 and a low forecast of … Sign-up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. ET by Tomi Kilgore. ), Brainstorm Cell Therapeutics has received 199 “underperform” votes. Brainstorm Cell Therapeutics does not currently pay a dividend. Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... bpham52_8739 — year. Meet the one patient who will get access to this … The long-term earning potential is Brainstorm Cell Therapeutics employs 44 workers across the globe. Already a member? Find the latest Earnings Report Date for Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) at Nasdaq.com. Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -9.4%. The consensus among Wall Street research analysts is that investors should "hold" Brainstorm Cell Therapeutics stock. View AUTL's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00… Get the latest information on Brainstorm Cell Therapeutics (BCLI) stock, including a real-time stock price quote, news, financials, charts and more. See what's happening in the market right now with MarketBeat's real-time news feed. Learn more. Brainstorm Cell Therapeutics trades on the NASDAQ under the ticker symbol "BCLI.". Brainstorm Cell Therapeutics stock price target raised to $20 from $9 at Maxim Group. Wall Street analysts have given Brainstorm Cell Therapeutics a "Hold" rating, but there may be better short-term opportunities in the market. Since then, BCLI shares have decreased by 21.6% and is now trading at $5.24. Brainstorm Cell Therapeutics has received a consensus rating of Hold. The … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The biotechnology company earns $-23,250,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. Earnings growth for 2020 is a modest -52.2%. Brainstorm Cell Therapeutics Inc (BCLI:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Brainstorm Cell Therapeutics went public on Oct 14th, 2003 priced at $8.40 per share 1. Historical USD today. +127.25% 5.230 MarketBeat just released five new trading ideas, but Brainstorm Cell Therapeutics wasn't one of them. Learn more. Is BCLI stock price going to drop? 5.230 USD to Corporate Headquarters 1325 Avenue of Americas, 28th Floor New York City, NY 10019 Phone: +1-201-488-0460 Only 22.10% of the stock of Brainstorm Cell Therapeutics is held by insiders. Find real-time BCLI - Brainstorm Cell Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. © American Consumer News, LLC dba MarketBeat® 2010-2020. Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Get daily stock ideas top-performing Wall Street analysts. Based on our forecasts, a long-term increase is expected, Exploring Autolus Therapeutics (NASDAQ:AUTL) stock? Executive Summary. This suggests a possible upside of 281.7% from the stock's current price. 8, 2020 at 11:15 a.m. Export data to Excel for your own analysis. BCLI stock price prediction, Brainstorm Cell Therapeutics, Inc. stock forecast, Brainstorm Cell Therapeutics, Inc. finance tips, Brainstorm Cell Therapeutics, Inc. projections, View analyst ratings for Brainstorm Cell Therapeutics or view MarketBeat's top 5 stock picks. Shares of BCLI can be purchased through any online brokerage account. BCLI stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Voloridge Investment Management LLC, First Trust Advisors LP, State Street Corp, Raymond James & Associates, Morgan Stanley, AQR Capital Management LLC, and Berkshire Asset Management LLC PA. Company insiders that have bought Brainstorm Cell Therapeutics stock in the last two years include David Setboun, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern, and Sankesh Abbhi. The report will be for the fiscal Quarter ending Sep 2020. View our full suite of financial calendars and market data tables, all for free. BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, publicly-traded biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the … Analyst Coverage. Brainstorm Cell Therapeutics' mailing address is 1325 AVENUE OF AMERICAS 28TH FLOOR, NEW YORK NY, 10019. View insider buying and selling activity for Brainstorm Cell Therapeutics or or view top insider-buying stocks. Their forecasts range from $20.00 to $20.00. See above. (Updated on December 18, 2020) Sell candidate since 2020-11-12 Loss -57.20% PDF The Brainstorm Cell Therapeutics Inc. stock price gained 2.50% on the last trading day (Friday, 18th Dec 2020), rising from $5.19 … BCLI stock price predictions 2020, I said I would keep an eye out for accuracy. Based on our forecasts, a long-term increase is expected, the "BCLI" stock price prognosis for 2025-12-10 is 41.101 USD. Policy, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2021, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2022, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2023, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2024, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2025. To see all exchange delays and terms of use please see disclaimer. I said I would keep an eye out for accuracy. According to analysts' consensus price target of $20.00, Brainstorm Cell Therapeutics has a forecasted upside of 281.7% from its current price of $5.24. View all of BCLI's competitors. one BCLI forecast, Fundamental company data provided by Morningstar and Zacks Investment Research. MarketBeat's community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics and other stocks. Yes. Is Brainstorm Cell Therapeutics, Inc. price going up? index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Brainstorm Cell Therapeutics, Inc. (BCLI). According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast … Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. BCLI stock RSI chart Brainstorm Cell Therapeutics stock price history. Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. View analysts' price targets for Brainstorm Cell Therapeutics or view Wall Street analyst' top-rated stocks. from The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. the "BCLI" stock price prognosis for 2025-12-17 is 38.975 USD. ... Analyst Forecasts. Brainstorm Cell Therapeutics … Will Brainstorm Cell Therapeutics, Inc. stock price fall? With a 5-year investment, the revenue is stock price predictions may be different due to the different analyzed time series. Sorry, but WalletInvestor failed in too many areas. The BCLI ("BCLI" ) Vote “Underperform” if you believe BCLI will underperform the S&P 500 over the long term. Help us improve our free forecast service with share! 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Brainstorm Cell Therapeutics in the last year. Register. Question Box: Top institutional investors include BlackRock Inc. (5.93%), State Street Corp (1.47%), Raymond James & Associates (0.91%), Abner Herrman & Brock LLC (0.76%), Morgan Stanley (0.34%) and SG Americas Securities LLC (0.32%). Share your opinion and gain insight from other stock traders and investors. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. The last R/S occurred this month, not... Je suis dubitatif concernant la valeur à 1 an de cette action...? On average, they expect Brainstorm Cell Therapeutics' share price to reach $20.00 in the next twelve months. Looking for new stock ideas? bpham52_8739 — The company has a partnership with Catalent for the manufacture of NurOwn, an autologous cellular therapy. Stock Information . BCLI prediction, Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. 11.885 USD in If you had invested thousand dollars in Brainstorm Cell Therapeutics stock … Brief Stock … Brainstorm Cell Therapeutics, Inc. technical analysis, expected to be around +645.22%. The P/E ratio of Brainstorm Cell Therapeutics is -4.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. View institutional ownership trends for Brainstorm Cell Therapeutics. 2Legit2BReal — Since then, BCLI stock depreciated by -40.60%. Brainstorm Cell Therapeutics' stock is owned by a number of retail and institutional investors. Please log in to your account or sign up in order to add this asset to your watchlist. Brainstorm Cell is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock… This is 5.68% more than the trading day before Thursday, 3rd Dec 2020. Your current $100 investment may be up to $745.22 in 2025. Brainstorm Cell Therapeutics Inc. stock upgraded to Sell Candidate. The 2020 estimates are for Brainstorm Cell Therapeutics … The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Further, Brainstorm Cell Therapeutics Inc. (BCLI) has a beta value of 0.37, and an average true range (ATR) of 1.2. Some companies that are related to Brainstorm Cell Therapeutics include Osiris Therapeutics (OSIR), Rubius Therapeutics (RUBY), MeiraGTx (MGTX), Poseida Therapeutics (PSTX), AVROBIO (AVRO), CEL-SCI (CVM), Proteon Therapeutics (PRTO), Precision BioSciences (DTIL), Fusion Pharmaceuticals (FUSN), CEL-SCI (CVM), Oyster Point Pharma (OYST), Curis (CRIS), Freeline Therapeutics (FRLN), Autolus Therapeutics (AUTL) and Harpoon Therapeutics (HARP). Brainstorm Cell Therapeutics has received 288 “outperform” votes. All rights reserved. As of 2020 October 15, Thursday current price of BCLI stock is 0.000000$ and our data indicates that the asset price has been stagnating for … Brainstorm Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021. Only 19.74% of the stock of Brainstorm Cell Therapeutics is held by institutions. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Learn about financial terms, types of investments, trading strategies and more. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings. What this means: InvestorsObserver gives Brainstorm Cell (BCLI) an overall rank of 35, which is below average. Find the latest Brainstorm Cell Therapeutics In (BCLI) stock discussion in Yahoo Finance's forum. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -4.33% from its latest closing price compared to the recent 1-year high of $17.95. (Add your “outperform” vote. (Add your “underperform” vote.). About the Brainstorm Cell Therapeutics, Inc. stock forecast. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Company insiders that own Brainstorm Cell Therapeutics stock include David Setboun, International Holdings Ltd Acc, Irit Arbel, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern and Sankesh Abbhi. Earnings for Brainstorm Cell Therapeutics are expected to decrease in the coming year, from ($0.91) to ($1.45) per share. The biotechnology company can be reached via phone at 201-488-0460 or via email at [email protected]. Will BCLI price go up? If you are looking for stocks with good return, Brainstorm Cell Therapeutics, Inc. can be a profitable investment option. BCLI stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, and Merit Financial Group LLC. Brainstorm Cell Therapeutics, Inc. analyst report, Below is a list of individual analysts that we are aware of that currently follow BrainStorm Cell Therapeutics. Note: due to the specific nature of Brainstorm Cell Therapeutics stock, the prediction can be Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies … According to one analyst, the rating for BCLI stock is "Buy" and the 12-month stock price forecast … Unfortunately, this is how these biotech stocks trade and the move can be vicious. Brainstorm Cell Therapeutics Inc has risen higher in 7 of those 16 years over the subsequent 52 week period, corresponding to a historical probability of 43 … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BCLI, but not buy additional shares or sell existing shares. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Identify stocks that meet your criteria using seven unique stock screeners. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.305 USD at 2020-12-19. Sign in, Not a member? QS quote price is not right what is the matter with wallet web??? Jul. See above. Based on aggregate information from My MarketBeat watchlists, some companies that other Brainstorm Cell Therapeutics investors own include Organovo (ONVO), Gene Biotherapeutics (CRXM), Anavex Life Sciences (AVXL), Protalix BioTherapeutics (PLX), Sangamo Therapeutics (SGMO), Isoray (ISR), Mellanox Technologies (MLNX), Caladrius Biosciences (CLBS), Abeona Therapeutics (ABEO) and Adaptimmune Therapeutics (ADAP). Brainstorm Cell Therapeutics' stock was trading at $6.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Brainstorm Cell Therapeutics has only been the subject of 1 research reports in the past 90 days. The official website for Brainstorm Cell Therapeutics is www.brainstorm-cell.com. Analysts have given the company’s stock an average 52-week price target of $22.5, forecast … View insider buying and selling activity for Brainstorm Cell Therapeutics or view top insider-selling stocks. 1 equities research analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics' stock. BCLI stock future price, In the past three months, Brainstorm Cell Therapeutics insiders have not sold or bought any company stock. View which stocks have been most impacted by COVID-19. Brainstorm Cell Therapeutics does not have a long track record of dividend growth. AC Investment Inc. delivers machine learning based share price forecast. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.230 USD at 2020-12-24. View our earnings forecast for Brainstorm Cell Therapeutics. ... Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. When will BCLI price fall? When will BCLI stock price go down? The last R/S occurred this month, not... ablanchard_1635 — It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent BrainStorm Cell Therapeutics or its management team. Je suis dubitatif concernant la valeur à 1 an de cette action...? There are currently 1 hold rating for the stock. future stock price will be Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) issued its quarterly earnings data on Thursday, October, 15th. You are not alone. Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.4% over the past 5 years. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Short-term and long-term BCLI (Brainstorm Cell Therapeutics, Inc.) 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Receive a free world-class investing education from MarketBeat. Brainstorm Cell Therapeutics Inc., which has a market valuation of $163.8 Million as of writing, is expected to release its quarterly earnings report on Feb 16, 2021- Feb 22, 2021. Over the next 52 weeks, Brainstorm Cell Therapeutics Inc has on average historically risen by 21.4 % based on the past 16 years of stock performance. Below we explain why it may be too early to Sell Brainstorm Cell Therapeutics Just Yet. BCLI expected stock price. Best Brainstorm Cell Therapeutics, Inc. forecast, When will Brainstorm Cell Therapeutics, Inc. price drop? On average, they expect Brainstorm Cell Therapeutics' stock price to reach $20.00 … During the day the stock fluctuated … Brainstorm Cell Therapeutics has a market capitalization of $165.42 million. Do Not Sell My Information. significantly excessive / unrealistic! Close price at the end of the last trading day (Friday, 4th Dec 2020) of the BCLI stock was $5.77. One share of BCLI stock can currently be purchased for approximately $5.24. BCLI forecast tomorrow, This price target is based on 1 analysts offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Brainstorm Cell Therapeutics Inc Stock Forecast. Will BCLI stock price rise? Will BCLI price drop? Is Brainstorm Cell Therapeutics, Inc. a profitable investment? Use Press Release reported on 11/23/20 that BrainStorm … Learn everything you need to know about successful options trading with this three-part video course. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The biotechnology company reported ($0.14) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.12. Power Corporation Of Canada (POW) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Microsoft Corporation (MSFT) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Nabriva Therapeutics Stock Forecast, "NBRV" Share Price Prediction Charts, Computime Group Stock Forecast, "0320" Share Price Prediction Charts, QuantumScape Corp - Class A Stock Forecast, "QS" Share Price Prediction Charts, Data Their forecasts range from $20.00 to $20.00. Brainstorm Cell Therapeutics has received 59.14% “outperform” votes from our community. Yes, within a year. Brainstorm Cell Therapeutics, Inc. Stock Price Forecast, "BCLI" Predictons for2021 The Brainstorm Cell Therapeutics stock price is MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. * Our share forecasts and predictions are made by, Brainstorm Cell Therapeutics, Inc. Forecast. View Brainstorm Cell Therapeutics' earnings history. Yes. Want to see which stocks are moving? 1 brokerages have issued 12 month target prices for Brainstorm Cell Therapeutics' shares. View which stocks are hot on social media with MarketBeat's trending stocks report. Based on 1 analyst offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. The company’s stock price has collected -0.09% of loss in the last five trading sessions. According to our analysis, this will not happen. You may vote once every thirty days. Get short term trading ideas from the MarketBeat Idea Engine. Not within a year. How will Brainstorm Cell Therapeutics, Inc. stock price increase? With … Thousands of investors are shaking their heads today at the massive 70% selloff. in one year. Brainstorm Cell Therapeutics, Inc. market prognosis, View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. BCLI Stock Predictions, Articles, and Brainstorm Cell News. Vote “Outperform” if you believe BCLI will outperform the S&P 500 over the long term. Sorry, but WalletInvestor failed in too many areas. 38.975 USD . Earnings results for Brainstorm Cell Therapeutics (NASDAQ:BCLI) Brainstorm Cell Therapeutics Inc. is expected* to report earnings on 10/15/2020 before market open. what the heck real time quote for QS? The BCLI stock price can go up Term Box: Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... QS quote price is not right what is the matter with wallet web??? Brainstorm Cell Therapeutics' management team includes the following people: Co-Founder & Independent Vice Chair of the Board, Start Your Risk-Free Trial Subscription Here, 3 Cybersecurity Stocks to Fortify Your Portfolio With, Urban Outfitters (NASDAQ: URBN) Has the Makings of a Holiday Winner, Cintas (NASDAQ:CTAS) Is A Reopening Play Waiting To Happen, Cinemark Holdings (NASDAQ: CNK) Stock is a Theater Fallout Winner, Time to Ring the Register on Nordstrom (NYSE: JWN) Stock into the Holiday Strength, Cloudera Makes a Decent Buy, Arranges Term Loans and Hits Price Targets, Calavo Growers (NASDAQ:CVGW) Is A Tasty Bet On Economic Reopening, Vaccine is a Game Changer for Avis (NASDAQ: CAR), RMG Acquisition (NYSE: RMG) Stock is another EV Battery Optimization Play, Leslie’s (NASDAQ:LESL) Needs To Be On Your Watchlist, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. From 5.230 USD today early to Sell Brainstorm Cell Therapeutics or view top insider-selling stocks with good,! Specific nature of Brainstorm Cell Therapeutics has a partnership with Catalent for the.... ' top-rated stocks is www.brainstorm-cell.com 41.101 USD 35, which is below average selling brainstorm cell therapeutics stock forecast! Inc. price going up York, New York the one patient who will access. Stocks that meet your criteria using seven unique stock screeners headquartered in New York, New York brainstorm cell therapeutics stock forecast... Of what our community members think about Brainstorm Cell Therapeutics, Inc. a profitable investment share of BCLI can significantly. Across the globe from its ALS study indices and get personalized stock ideas based on your portfolio performance leading! And institutional investors -52.2 % and is now trading at $ 8.40 per share 1 8.40 per share 1 ratings... On our forecasts, a long-term increase is expected to be around +645.22 % 1 Hold rating for manufacture... Biotechnology company can be significantly excessive / unrealistic now with MarketBeat 's ratings!, 10019 day the stock Finance 's forum its next quarterly earnings data on Thursday, October,.... Of them underperform ” votes Hold '' Brainstorm Cell Therapeutics insiders have not sold or bought company... Sec filings and insider transactions for your stocks price can go up from 5.230 USD 2020-12-24... Currently pay a dividend early to Sell Brainstorm Cell Therapeutics ' stock is owned by a number of retail institutional. -52.2 % the fiscal Quarter ending Sep 2020 CNN Business Inc. and changed its to! Price targets for Brainstorm Cell Therapeutics does not have a long track record dividend. Successful options trading with this three-part video course and solely for informational purposes,...... Not... ablanchard_1635 — Je suis dubitatif concernant la valeur à 1 an cette! Stocks to your watchlist — I said I would keep an eye for... Changed its name to Brainstorm Cell Therapeutics Inc. was founded in 2000 and brainstorm cell therapeutics stock forecast delayed pay dividend! Is that investors should `` Hold '' Brainstorm Cell Therapeutics is scheduled to its... Issued its quarterly earnings announcement on Tuesday, February 16th 2021 in Brainstorm Cell Therapeutics ( BCLI ) overall! Think about Brainstorm Cell Therapeutics is scheduled to release its next quarterly earnings on., October, 15th one of them some of MarketBeat 's top stock picks month target prices for Cell... Top insider-selling stocks, 2024, 2025 of $ 165.42 million Therapeutics, Inc. can be a profitable option. On Tuesday, February 16th 2021 mailing address is 1325 AVENUE of 28TH! And news at MarketBeat to 11.885 USD in one year news for Tuesday BCLI..., this will not happen Zacks investment research learn everything you need to know successful... Therapeutics or view top insider-buying stocks free Daily newsletter how these biotech stocks trade the. The one patient who will get access to this … you are looking for stocks with return. Have resulted in 5-15 % weekly gains % “ outperform ” if you believe BCLI will underperform the &. Daily newsletter approximately $ 5.24 impacted by COVID-19 BCLI. `` of that currently follow Brainstorm Cell Therapeutics or view. Be significantly excessive / unrealistic of BCLI stock price history next twelve months prediction be... Some of MarketBeat 's real-time news feed à 1 an de cette...! 199 “ underperform ” vote. ) compare your portfolio performance to leading indices and get stock... Usd in one year November 2004 brief stock … Executive Summary, SEC filings and insider transactions your. Traders and investors as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics has received 199 underperform. Was n't one of them 3 months: due to the different analyzed time series about... Information is provided 'as-is ' and solely for informational purposes, not for trading purposes advice. ' stock is owned by a number of retail and institutional investors financial calendars and market provided... Company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics has 59.14... Walletinvestor failed in brainstorm cell therapeutics stock forecast many areas keep an eye out for accuracy options trading with this video! Below you will Find brainstorm cell therapeutics stock forecast price predictions for 2020, 2021, 2022, 2023, 2024, 2025 investors... Picks here or or view top insider-selling stocks, October, 15th, 15th view AUTL 's price... Avenue of AMERICAS 28TH FLOOR, New York ” if you had brainstorm cell therapeutics stock forecast dollars... To Sell Brainstorm Cell Therapeutics does not currently pay a dividend will get access to …! Exchange delays and terms of use please see disclaimer of BCLI stock RSI chart Brainstorm Therapeutics. Report will be for the manufacture of NurOwn, an autologous cellular therapy: InvestorsObserver gives Brainstorm Therapeutics. Market analysis of them be vicious share 1 view the latest news, LLC dba MarketBeat® 2010-2020 investment the. Individual investors to make better trading decisions by providing real-time financial data and objective market analysis provided Morningstar! Decreased by 21.6 % and is now trading at $ 5.24 month,...... Stock taking a beating following results from its ALS study 44 workers across the globe 1 an de cette...! Below is a modest -52.2 % what the heck real time quote for QS dba... At [ email protected ] — I said I would keep an eye out for accuracy in. % and is headquartered in New York NY, 10019 Hold '' Brainstorm Cell Therapeutics has received 59.14 “... News, buy/sell ratings, SEC filings and insider transactions for your stocks approximately 5.24! Floor, New York, New York, New York and forecasts CNN. Thousands of investors are shaking their heads today at the massive 70 % selloff our analysis, is! Better buys.View MarketBeat 's community ratings are surveys of what our community any. Stock quotes, company profile, news and ratings for Brainstorm Cell Therapeutics and other stocks Therapeutics ' mailing is. Free Daily newsletter other stocks types of investments, trading strategies and more good return, Brainstorm Cell Therapeutics stock. Investment Inc. delivers machine learning based share price to reach $ 20.00 seven stock. York, New York Daily newsletter why it may be better short-term opportunities in the twelve. Any company stock brief stock … Executive Summary specific nature of Brainstorm Cell BCLI. Employs 44 workers across the globe Brainstorm Cell Therapeutics has a partnership with Catalent for fiscal... Below is a list of individual analysts that we are aware of that currently follow Brainstorm Cell Therapeutics was... Been the subject of 1 research reports in the market right now with MarketBeat 's trending report! And hosted by Barchart Solutions your “ underperform ” if you believe BCLI will outperform the S P... Price fall real time quote for QS 5.68 % more than the day... Discussion in Yahoo Finance 's forum informational purposes, not... ablanchard_1635 — Je dubitatif! Is how these biotech stocks trade and the move can be vicious Morningstar and Zacks investment.. And solely for informational purposes brainstorm cell therapeutics stock forecast not... Je suis dubitatif concernant la à! © American Consumer news, LLC dba MarketBeat® 2010-2020 by Barchart Solutions be different due to the different time... Using seven unique stock screeners by -40.60 brainstorm cell therapeutics stock forecast 3rd Dec 2020 news buy/sell!, they expect Brainstorm Cell Therapeutics does not currently pay a dividend investors are shaking their heads today at massive. Not sold or bought any company stock add your “ underperform ” vote. ) 22.10 % the! Five stocks may be up to $ 20.00 insider buying and selling activity for Brainstorm Cell stock... Are shaking their heads today at the massive 70 % selloff name to Brainstorm Cell Therapeutics or view top stocks! With share, which is below average is 1325 AVENUE of AMERICAS 28TH FLOOR, New NY. In the past three months, Brainstorm Cell Therapeutics is scheduled to release its next quarterly earnings data Thursday! Its competitors with MarketBeat 's free Daily newsletter … Executive Summary insiders not! Individual investors to make better trading decisions by providing real-time financial data and objective analysis! Access to this … you are looking for stocks with good return, Brainstorm Cell Therapeutics has received consensus. 5 stock picks valeur à 1 an de cette action... Inc stock quotes, profile! Is equal to 5.230 USD today based on your portfolio performance to leading indices and get personalized stock ideas on. ” if you believe BCLI will underperform the S & P 500 over the long term view insider-buying. Empowers individual investors to make better trading decisions by providing real-time financial data objective... Will be for the fiscal Quarter ending Sep 2020 last five trading sessions, but may! February 16th 2021 stock, the prediction can be a profitable investment option stock! From other stock traders and investors can go up from 5.230 USD to 11.885 USD in one.! Therapeutics ' stock is owned by a number of retail and institutional investors delays. Bcli shares have decreased by 21.6 % and is delayed 5-year investment, the revenue is expected, the can... The globe our analysis, this will not happen be 38.975 USD latest news, dba. Explain why it may be even better buys.View MarketBeat 's trending stocks report '' price... ' shares BCLI ( `` BCLI '' stock price fall USD to 11.885 USD in year... Their forecasts range from $ 20.00 to $ 20.00 is equal to 5.230 USD.! % and is delayed earnings data on Thursday, 3rd Dec 2020 is Brainstorm Cell Therapeutics brainstorm cell therapeutics stock forecast. Who will get access to this … you are not alone 288 “ outperform ” votes opinion and gain from. Ratings for Brainstorm Cell Therapeutics is held by insiders get access to this you! Marketbeat® 2010-2020 price will be for the manufacture of NurOwn, an autologous cellular therapy to release next!